• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    74 Biggest Movers From Yesterday

    6/3/22 5:50:47 AM ET
    $ACOR
    $AGLE
    $AHI
    $AI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACOR alert in real time by email

    Gainers

    • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) shares gained 47.5% to settle at $0.8436 on Thursday. Based on the review of approximately 460 patients, Data Safety and Monitoring Board (DSMB) recently determined that the evaluation of NRx Pharmaceuticals’ Zyesami (aviptadil) should cease due to futility.
    • Repare Therapeutics Inc. (NASDAQ:RPTX) surged 44.8% to close at $12.67 on Thursday after the company announced it has entered into a worldwide license and collaboration agreement with Roche for the development and commercialization of camonsertib. Repare will receive a $125 million upfront payment and is eligible to receive up to an additional $1.2 billion in potential milestones.
    • Talkspace, Inc. (NASDAQ:TALK) gained 34.4% to close at $1.76. Hearing Citibank said it believes that the company will be acquired.
    • EBET, Inc. (NASDAQ:EBET) rose 33.6% to settle at $3.68.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) jumped 29.2% to close at $2.39 after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an animal study in Soft Tissue Sarcoma (STS).
    • Credo Technology Group Holding Ltd (NASDAQ:CRDO) surged 26.2% to close at $12.94 after the company reported Q4 EPS results up from last year and better-than-expected sales results. The company also issued Q1 sales guidance above analyst estimates.
    • Avaya Holdings Corp. (NYSE:AVYA) surged 25.6% to close at $5.35.
    • Chewy, Inc. (NYSE:CHWY) jumped 24.2% to close at $29.18 after the company reported better-than-expected Q1 sales results.
    • Integrated Media Technology Limited (NASDAQ:IMTE) surged 23.7% to settle at $9.92.
    • The Singing Machine Company, Inc. (NASDAQ:MICS) gained 22.5% to close at $3.48.
    • Spruce Biosciences, Inc. (NASDAQ:SPRB) rose 20.6% to settle at $1.76. Spruce Biosciences was recently granted US patent 'Corticotropin Releasing Factor Receptor Antagonists.'
    • PyroGenesis Canada Inc. (NASDAQ:PYR) surged 19.9% to close at $3.07. PyroGenesis announced project to introduce plasma torches into the upstream anode baking process.
    • InnovAge Holding Corp. (NASDAQ:INNV) jumped 19.9% to close at $5.55.
    • American Superconductor Corporation (NASDAQ:AMSC) rose 19.7% to close at $6.32 following Q4 results.
    • Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) jumped 19.5% to settle at $5.22. Marinus Pharmaceuticals, last month, posted a Q1 loss of $0.52 per share.
    • Bon Natural Life Limited (NASDAQ:BON) gained 19.4% to close at $5.04.
    • Dunxin Financial Holdings Limited (NYSE:DXF) surged 19% to close at $0.5889.
    • Elastic N.V. (NYSE:ESTC) climbed 18.9% to close at $73.62 after the company reported better-than-expected Q4 EPS and sales results.
    • Heliogen, Inc. (NYSE:HLGN) gained 18.9% to settle at $4.53. Heliogen recently posted a Q1 loss of $0.32 per share.
    • MongoDB, Inc. (NASDAQ:MDB) climbed 18.6% to close at $286.70 after the company reported Q1 EPS results up from last year and better-than-expected sales results. The company also issued Q2 sales guidance above analysts’ estimates.
    • Pure Storage, Inc. (NYSE:PSTG) shares climbed 18.2% to close at $28.37 after the company reported better-than-expected Q1 financials results. The company also issued Q2 and FY23 sales guidance above analyst estimates.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) gained 18.2% to close at $6.63 after declining over 16% on Wednesday.
    • Uranium Energy Corp. (NYSE:UEC) surged 18% to settle at $4.19.
    • RISE Education Cayman Ltd (NASDAQ:REDU) jumped 17.9% to close at $1.65.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) jumped 17.6% to close at $2.94.
    • Onconova Therapeutics, Inc. (NASDAQ:ONTX) gained 17.5% to close at $1.34.
    • Cytek Biosciences, Inc. (NASDAQ:CTKB) rose 17.2% to settle at $11.33. Cytek recently said it received CE Marking for series of cFluor Reagents, TBNK Kit.
    • GitLab Inc. (NASDAQ:GTLB) jumped 17.1% to close at $44.90.
    • MicroVision, Inc. (NASDAQ:MVIS) surged 16.9% to close at $4.01.
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) gained 16.8% to close at $1.46.
    • Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) jumped 16.8% to close at $3.48.
    • UiPath Inc. (NYSE:PATH) shares gained 16.7% to close at $19.64 after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q3 and FY23 sales guidance above analysts’ estimates.
    • Nyxoah S.A. (NASDAQ:NYXH) rose 16.7% to close at $13.76.
    • Missfresh Limited (NASDAQ:MF) jumped 16.6% to close at $0.2857 after gaining over 51% on Wednesday.
    • Nu Holdings Ltd. (NYSE:NU) rose 16.2% to settle at $4.44.
    • KE Holdings Inc. (NYSE:BEKE) jumped 16% to close at $14.70. KE Holdings recently announced better-than-expected Q1 sales results.
    • Gevo, Inc. (NASDAQ:GEVO) climbed 15.9% to close at $4.74. Gevo, last month, reported better-than-expected Q1 sales results.
    • HashiCorp, Inc. (NASDAQ:HCP) gained 15.9% to close at $41.27. The company ppsted upbeat quarterly results.
    • Exscientia plc (NASDAQ:EXAI) rose 15.7% to settle at $13.54. Exscientia recently posted a Q1 loss of $0.41 per share.
    • electroCore, Inc. (NASDAQ:ECOR) surged 15.6% to close at $0.5955.
    • 111, Inc. (NASDAQ:YI) gained 15.6% to settle at $2.15.
    • Intrusion Inc. (NASDAQ:INTZ) rose 15.3% to close at $3.25. Intrusion reported a partnership with Innercore Technologies and multi-year deal.
    • Veeva Systems Inc. (NYSE:VEEV) gained 14.7% to close at $192.55 after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 and FY22 EPS guidance above analysts’ estimates.
    • Aqua Metals, Inc. (NASDAQ:AQMS) rose 14.4%to settle at $0.9434.
    • comScore, Inc. (NASDAQ:SCOR) rose 12.9% to close at $2.19. comScore Director Paul William Livek acquired a total of 600,000 shares at an average price of $1.92.
    • Lands' End, Inc. (NASDAQ:LE) gained 12.8% to close at $12.57 after the company reported better-than-expected Q1 EPS results.
    • Rain Therapeutics Inc. (NASDAQ:RAIN) jumped 12.7% to close at $2.75. Roth Capital initiated coverage on Rain Therapeutics with a Buy rating and announced a price target of $16.
    • Blue Apron Holdings, Inc. (NYSE:APRN) climbed 10.8% to settle at $3.40 after the company announced it will be offering a selection of meal kits without a subscription on Walmart.com.
    • Pineapple Energy Inc. (NASDAQ:PEGY) gained 10.1% to close at $2.30.

     

    Losers

    • Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) shares fell 51.3% to close at $0.73 on Thursday. Aeglea BioTherapeutics announced the U.S. Food and Drug Administration (FDA) has refused to accept the company’s Biologics License Application (BLA) with a Refusal to File (RTF) letter.
    • Immunic, Inc. (NASDAQ:IMUX) shares tumbled 46.8% to settle at $3.14 after the company reported data from its Phase 2 CALDOSE-1 trial of Vidofludimus Calcium did not achieve the primary endpoint.
    • Zosano Pharma Corporation (NASDAQ:ZSAN) dipped 43.2% to close at $1.00 after the company announced it filed a voluntary petition for relief under chapter 11.
    • Centessa Pharmaceuticals plc (NASDAQ:CNTA) fell 27.8% to close at $3.25 after the company announced it has made a strategic decision to discontinue development of lixivaptan for Autosomal Dominant Polycystic Kidney Disease including both the Phase 3 ACTION study and the open-label ALERT study.
    • CN Energy Group. Inc. (NASDAQ:CNEY) fell 26.3% to close at $1.51.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) dipped 25% to close at $0.3334.
    • Limelight Networks, Inc. (NASDAQ:LLNW) fell 16.1% to close at $2.92.
    • Innovid Corp. (NYSE:CTV) fell 15.5% to close at $2.99.
    • Genocea Biosciences, Inc. (NASDAQ:GNCA) dropped15% to close at $0.0510.
    • Nutex Health, Inc. (NASDAQ:NUTX) fell 14.5% to close at $9.21.
    • Gracell Biotechnologies Inc. (NASDAQ:GRCL) fell 14.4% to settle at $2.73. Cantor Fitzgerald recently initiated coverage on Gracell Biotechnologies with an Overweight rating and announced a price target of $20.
    • Mullen Automotive, Inc. (NASDAQ:MULN) fell 13.4% to close at $1.23. Mullen Automotive recently announced results of its solid-state polymer battery testing with the Battery Innovation Center in Indiana.
    • Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) shares fell 12.7% to close at $4.68 after the company priced its common stock offering of 10 million shares at $4.75 per share.
    • Histogen Inc. (NASDAQ:HSTO) shares fell 12.7% to close at $0.1371. Histogen reported a 1-for-20 reverse stock split.
    • WiSA Technologies, Inc. (NASDAQ:WISA) fell 12.6% to close at $0.70.
    • Lightwave Logic, Inc. (NASDAQ:LWLG) fell 12.5% to close at $6.94.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) dipped 12.5% to settle at $3.02.
    • Midatech Pharma plc (NASDAQ:MTP) dropped 12% to close at $0.66. The U.S. Food and Drug Administration (FDA) recently granted Fast Track Designation to Midatech Pharma PLC's (NASDAQ:MTP) lead drug candidate MTX110 for the treatment of patients with recurrent glioblastoma (rGBM).
    • Advanced Human Imaging Limited (NASDAQ:AHI) fell 9.3% to close at $0.7378.
    • Energy Focus, Inc. (NASDAQ:EFOI) fell 9% to close at $1.11 after jumping 37% on Wednesday.
    • CASI Pharmaceuticals, Inc. (NASDAQ:CASI) fell 8.6% to close at $3.71 following effect of 1:10 reverse stock split.
    • Enjoy Technology, Inc. (NASDAQ:ENJY) fell 8.2% to close at $0.2619.
    • Conn's, Inc. (NASDAQ:CONN) fell 7.5% to close at $11.59. The company reported mixed results for its first quarter.
    • Hewlett Packard Enterprise Company (NYSE:HPE) fell 5.2% to close at $14.96 after the company reported worse-than-expected Q2 financials results. The company also issued Q3 and FY22 EPS guidance with midpoints below analyst estimates.
    • C3.ai, Inc. (NYSE:AI) shares fell 5% to close at $17.62 after the company issued Q1 and FY23 sales guidance below analyst estimates.
    Get the next $ACOR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACOR
    $AGLE
    $AHI
    $AI

    CompanyDatePrice TargetRatingAnalyst
    Elastic N.V.
    $ESTC
    4/23/2026$49.00Neutral
    Rothschild & Co Redburn
    GitLab Inc.
    $GTLB
    4/22/2026$27.00Buy → Neutral
    BofA Securities
    Elastic N.V.
    $ESTC
    4/21/2026$50.00Neutral
    Goldman
    GitLab Inc.
    $GTLB
    4/20/2026$25.00Outperform → Sector Perform
    RBC Capital Mkts
    Immunic Inc.
    $IMUX
    4/17/2026$2.50Buy
    Stifel
    GitLab Inc.
    $GTLB
    4/16/2026$24.00Buy → Neutral
    UBS
    Immunic Inc.
    $IMUX
    4/15/2026Buy → Hold
    D. Boral Capital
    Credo Technology Group Holding Ltd
    $CRDO
    4/13/2026$175.00Buy
    Jefferies
    More analyst ratings

    $ACOR
    $AGLE
    $AHI
    $AI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

    For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

    12/14/23 9:00:20 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    May 13, 2021 - FDA In Brief: FDA Releases Investigation Report Following 2020 Salmonella Outbreak Linked to Red Onions

    For Immediate Release: May 13, 2021 The following quote is attributed to Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response “The FDA has been working with the CDC, state partners and Canadian officials to investigate the largest Salmonella Newport outbreak in over a decade, which was linked to red onions. The FDA, today, released a 2020 Salmonella Outbreak Linked to Red Onions Report that includes an o

    5/13/21 3:17:14 PM ET
    $INTZ
    Computer Communications Equipment
    Telecommunications

    $ACOR
    $AGLE
    $AHI
    $AI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer-Healthcare Montgomery Pamela W. bought $7,021 worth of shares (79 units at $88.87), increasing direct ownership by 3% to 2,758 units (SEC Form 4)

    4 - Nutex Health Inc. (0001479681) (Issuer)

    3/16/26 3:02:43 PM ET
    $NUTX
    Real Estate

    Director Urban David bought $100,100 worth of shares (16,250 units at $6.16), increasing direct ownership by 35% to 62,471 units (SEC Form 4)

    4 - Eos Energy Enterprises, Inc. (0001805077) (Issuer)

    3/10/26 8:52:43 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Chief Executive Officer Mastrangelo Joe bought $157,262 worth of shares (23,900 units at $6.58), increasing direct ownership by 2% to 1,487,126 units (SEC Form 4)

    4 - Eos Energy Enterprises, Inc. (0001805077) (Issuer)

    3/5/26 8:48:21 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    $ACOR
    $AGLE
    $AHI
    $AI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    KE Holdings Inc. Releases 2025 Environmental, Social and Governance Report

    BEIJING, April 24, 2026 (GLOBE NEWSWIRE) -- KE Holdings Inc. ("Beike" or the "Company") (NYSE:BEKE, HKEX: 2423)), a leading integrated online and offline platform for housing transactions and services, today released its 2025 Environmental, Social and Governance report (the "2025 ESG Report"), highlighting Beike's ongoing efforts to strengthen its governance framework, enhance residential service experiences, empower industry participants through technology, and contribute to a sustainable future for the value chain, all underpinned by its mission of "Admirable service, joyful living." Mr. Stanley Yongdong Peng, Co-founder, Chairman of the Board, and Chief Executive Officer of Beike, comm

    4/24/26 7:14:03 AM ET
    $BEKE
    Real Estate
    Finance

    KE Holdings Inc. Files Its Annual Report on Form 20-F

    BEIJING, April 24, 2026 (GLOBE NEWSWIRE) -- KE Holdings Inc. ("Beike" or the "Company") (NYSE:BEKE), a leading integrated online and offline platform for housing transactions and services, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission on April 24, 2026. The annual report can be accessed on the Company's investor relations website at https://investors.ke.com. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Company's I

    4/24/26 7:13:43 AM ET
    $BEKE
    Real Estate
    Finance

    KE Holdings Inc. to Hold Annual General Meeting on June 12, 2026

    BEIJING, April 24, 2026 (GLOBE NEWSWIRE) -- KE Holdings Inc. ("Beike" or the "Company") (NYSE:BEKE), a leading integrated online and offline platform for housing transactions and services, today announced that it will hold an annual general meeting of the Company's shareholders (the "AGM") at 3:00 p.m. Beijing time on Friday, June 12, 2026 at Oriental Electronic Technology Building, No. 2 Chuangye Road, Haidian District, Beijing, PRC, for the purposes of considering and, if thought fit, passing each of the Proposed Resolutions as defined and set forth in the notice of the AGM (the "AGM Notice"). A circular of the Company dated April 24, 2026 in relation to the AGM, the AGM Notice and the f

    4/24/26 6:27:08 AM ET
    $BEKE
    Real Estate
    Finance

    $ACOR
    $AGLE
    $AHI
    $AI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rothschild & Co Redburn initiated coverage on Elastic with a new price target

    Rothschild & Co Redburn initiated coverage of Elastic with a rating of Neutral and set a new price target of $49.00

    4/23/26 7:55:51 AM ET
    $ESTC
    Computer Software: Prepackaged Software
    Technology

    GitLab downgraded by BofA Securities with a new price target

    BofA Securities downgraded GitLab from Buy to Neutral and set a new price target of $27.00

    4/22/26 7:53:14 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Goldman initiated coverage on Elastic with a new price target

    Goldman initiated coverage of Elastic with a rating of Neutral and set a new price target of $50.00

    4/21/26 7:32:58 AM ET
    $ESTC
    Computer Software: Prepackaged Software
    Technology

    $ACOR
    $AGLE
    $AHI
    $AI
    SEC Filings

    View All

    SEC Form S-3 filed by MicroVision Inc.

    S-3 - MICROVISION, INC. (0000065770) (Filer)

    4/24/26 5:20:23 PM ET
    $MVIS
    Industrial Machinery/Components
    Technology

    Amendment: SEC Form S-3/A filed by Allarity Therapeutics Inc.

    S-3/A - Allarity Therapeutics, Inc. (0001860657) (Filer)

    4/24/26 1:01:50 PM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by KE Holdings Inc

    6-K - KE Holdings Inc. (0001809587) (Filer)

    4/24/26 7:45:44 AM ET
    $BEKE
    Real Estate
    Finance

    $ACOR
    $AGLE
    $AHI
    $AI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Cheng Chi Fung sold $5,170,522 worth of Ordinary Shares (27,500 units at $188.02) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Credo Technology Group Holding Ltd (0001807794) (Issuer)

    4/24/26 3:06:32 PM ET
    $CRDO
    Semiconductors
    Technology

    SEC Form 4 filed by Director Reed Michael Lee

    4 - Nutex Health Inc. (0001479681) (Issuer)

    4/24/26 2:35:38 PM ET
    $NUTX
    Real Estate

    SEC Form 4 filed by Director Saunders Scott J

    4 - Nutex Health Inc. (0001479681) (Issuer)

    4/24/26 2:32:08 PM ET
    $NUTX
    Real Estate

    $ACOR
    $AGLE
    $AHI
    $AI
    Leadership Updates

    Live Leadership Updates

    View All

    Gevo Appoints Joan Cetera as Vice President, Communications and Public Relations

    ENGLEWOOD, Colo., April 13, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in renewable fuels and chemicals and carbon management, today announced the appointment of Joan Cetera as Vice President of Communications and Public Relations, further supporting Gevo's broader leadership transition. Joan brings extensive experience leading enterprise communications for publicly traded companies, with expertise spanning executive communications, reputational management and communications strategy during periods of organizational change. Over her more than 20-year career, she has partnered closely with senior leadership teams to align external perception with business strategy and stak

    4/13/26 4:01:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer

    Mr Tyson has both clinical experience treating patients with serious mental health disorders and 25 years of successful industry commercial experience in the development and sales of medications in this fieldMr. Tyson is appointed as NRx anticipates approval of an ANDA for preservative-free ketamine and near term submission of a New Drug Application to expand ketamine labeling to encompass depression and suicidality. WILMINGTON, Del., April 13, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a biopharmaceutical company that focuses on neuroplastic therapies for depression, PTSD, and related conditions, today announces the appointment of Glenn Tyson as the company's first

    4/13/26 7:00:00 AM ET
    $NRXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Flow Sciences Appoints Michael Gesser as Chief Financial Officer

    Life Sciences Finance Veteran and Flow Sciences Board Member Steps Into CFO Role to Support Company's Next Phase of GrowthRALEIGH, N.C, April 8, 2026 /PRNewswire/ -- Flow Sciences, Inc., a global leader in advanced containment solutions for laboratory and pharmaceutical environments, today announced the appointment of Michael Gesser as its chief financial officer. Gesser, who has served as a member of the Flow Sciences board of directors since 2021, will continue serving on the board while assuming executive responsibility for all finance, accounting, tax, treasury, FP&A and investor relations functions.

    4/8/26 8:00:00 AM ET
    $ACOR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACOR
    $AGLE
    $AHI
    $AI
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Stock Movement: Insider Purchase at electroCore Inc. on Jun 6

    **Analysis of Recent Insider Purchase at electroCore Inc.** An insider purchase was recently made at electroCore Inc. by Goldberger Daniel S on June 6, 2024. This transaction involved the purchase of $247,587 worth of shares, equating to 38,505 units at an average price of $6.43 per share. As a result of this purchase, Goldberger's direct ownership in the company increased by 18% to 249,565 units, as reported in the SEC Form 4 filing. Looking at the historical insider transactions at electroCore Inc., several interesting patterns emerge when analyzing the timing, price, volume, purchaser's role, and more. On August 8, 2023, Goldstein Julie Ann and Cuneo F Peter both filed SEC Form 4 report

    6/10/24 12:57:57 AM ET
    $ECOR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ACOR
    $AGLE
    $AHI
    $AI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by Exscientia Plc

    SC 13G/A - Exscientia plc (0001865408) (Subject)

    11/22/24 9:11:55 PM ET
    $EXAI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Exscientia Plc

    SC 13D/A - Exscientia plc (0001865408) (Subject)

    11/22/24 8:00:16 PM ET
    $EXAI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACOR
    $AGLE
    $AHI
    $AI
    Financials

    Live finance-specific insights

    View All

    Eos Energy Enterprises Announces Date for First Quarter 2026 Financial Results and Conference Call; Announces Participation at Upcoming Investor Conferences

    EDISON, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ:EOSE) ("Eos" or the "Company"), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) manufactured in the United States, today announced it will release its first quarter 2026 financial results before the U.S. market opens on May 13, 2026. A conference call to discuss its results will take place the same morning at 8:30 a.m. Eastern Time. Eos partners with Say Technologies to allow retail and institutional shareholders to submit and vote on questions ahead of the earnings call. A selection of key question

    4/23/26 4:30:00 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026

    FREMONT, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), today announced that it will report financial results for the first quarter 2026 after market close on Thursday, May 7, 2026. The company's management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the "Investors" section of the company website at investors.cytekbio.com. About Cytek Biosciences, Inc.Cytek Biosciences (NASDAQ:CTKB) is a leading cell analysis solutions company advancing the next generation

    4/23/26 4:05:00 PM ET
    $CTKB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call

    HOUSTON, April 22, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Form 10-Q for the first fiscal quarter ended March 31, 2026, on Thursday, April 30, 2026 after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day. Nutex Health will host its earnings conference call on Friday, May 1, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and provide a b

    4/22/26 4:15:00 PM ET
    $NUTX
    Real Estate